News | August 25, 2008

Alsius Corp. Receives 510(k) Clearance for Invasive Solex Heat Exchange Catheter

August 26, 2008 - Alsius Corp., manufacturer of intravascular temperature management (IVTM) therapies, today said the FDA granted 510(k) clearance to market its Solex heat exchange catheter.

Solex is a new catheter offering maximum heat exchange power from a standard neck insertion, while providing triple lumen central venous access, the company said.

The Solex is the newest addition to Alsius’ family of catheters for use with the company’s Thermogard XP and CoolGard 3000 Intravascular Temperature Management Systems. Solex features a proprietary, serpentine balloon design that maximizes surface area contact on a relatively short, thin catheter.

Earlier this year, Alsius introduced the new Quattro catheter, a four-balloon heat exchange catheter that provides increased surface area and power for situations requiring insertion in the leg.

Approximately 20,000 critically ill patients have been treated with Alsius IVTM products since they first became available and, currently, more than 675 systems are in place at approximately 330 hospitals worldwide, the company said.

For more information:

Related Content

therapeutic hypothermia, children, cardiac arrest, treatment, temperature
Feature | May 04, 2015
A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain...
News | December 11, 2014
Researchers at Okayama University in collaboration with several medical centers in Japan have demonstrated the safety...
Feature | September 19, 2014
September 19, 2014 — According to a new study, peritoneal hypothermia is feasible for patients who have suffered ST-...
Technology | July 10, 2014
July 10, 2014 — Life Recovery Systems announced the U.S. Food and Drug Administration (FDA) has approved two...
therapeutic hypothermia, Philips InnerCool

The Philips InnerCool RTx system was used in the CHILL-MI study for use in STEMI patients.

Feature | February 03, 2014 | Dave Fornell
Use of therapeutic hypothermia is used to prevent neurological damage in patients who suffer sudden cardiac arrest (SCA...
BeneChill RhinoChill Therapeutic Hypothermia Cath Lab Intranasal Cooling System
News | January 22, 2014
BeneChill Inc. received the 2014 Frost & Sullivan Award for Technology Innovation Leadership for its RhinoChill...
rhinochill, RhinoChill, benechill, BeneChill

RhinoChill IntraNasal Cooling System

News | December 03, 2013
With the benefits of conventional strategies for therapeutic hypothermia following cardiac arrest being called in to ...
therapeutic hypothermia temperature management cath lab clinical trial study
Feature | November 01, 2013
clinical trial shows that rapidly cooling...
News | October 01, 2013
The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that...
News | August 06, 2013
Vanderbilt Heart and Vascular Institute is participating in the VELOCITY study, a randomized controlled clinical study...
Overlay Init